Prostate cancer diagnosed after initial biopsy with atypical small acinar proliferation suspicious for malignancy is similar to cancer found on initial biopsy

Urology

Volumn 60, Issue 5, 2002, Pages 851-854

  Iczkowski, Kenneth A ^a,b,d   Chen, Helen M ^b,d   Yang, Ximing J ^b,d   Beach, Robyn A ^c,d  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ACINAR CELL CARCINOMA; ADENOCARCINOMA; ADULT; AGE; ARTICLE; CANCER DIAGNOSIS; CANCER GRADING; CANCER SIZE; CANCER STAGING; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CARCINOMA; PROSTATECTOMY; TUMOR BIOPSY;

ADENOCARCINOMA; BIOPSY, NEEDLE; CASE-CONTROL STUDIES; CELL DIVISION; HUMANS; MALE; MIDDLE AGED; PRECANCEROUS CONDITIONS; PROSTATE; PROSTATECTOMY; PROSTATIC NEOPLASMS;

EID: 0036846727     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(02)01981-7     Document Type: Article

References (17)

1. Renshaw A.A., Santis W.F., Ritchie J.P. Clinicopathologic characteristics of prostatic adenocarcinoma in men with atypical prostate needle biopsies. J Urol. 159:1998;2018-2022.
2. Cheville J.C., Reznicek M.J., Clark J.R., et al. The focus of atypical glands suspicious for malignancy in prostate needle biopsy specimens incidence, histologic features, and clinical follow-up of cases diagnosed in a community practice . Am J Clin Pathol. 108:1997;633-640.
3. Bostwick D.G., Qian J., Frankel K. The incidence of high grade prostatic intraepithelial neoplasia in needle biopsies. J Urol. 154:1995;1791-1794.
4. Hoedemaeker R.F., Kraanse R., Rietbergen J.B., et al. Evaluation of prostate needle biopsies in a population-based screening study the impact of borderline lesions . Cancer. 85:1999;145-152.
5. Orozco R., O'Dowd G., Kunnel B., et al. Observations on pathology trends in 62,537 prostate biopsies obtained from urology practices in the United States. Urology. 51:1998;186-195.
6. Rogatsch H., Vollger W., Horninger W., et al. Diagnostic effect of a new preembedding method of prostate needle biopsy specimens. (abstract) Mod Pathol. 13:2000;110A.
7. Iczkowski K.A., Bostwick D.G. Criteria for biopsy diagnosis of minimal volume prostatic adenocarcinoma analytic comparison with nondiagnostic but suspicious, atypical small acinar proliferation . Arch Pathol Lab Med. 124:2000;98-107.
8. Iczkowski K.A., MacLennan G.T., Bostwick D.G. Atypical small acinar proliferation of the prostate suspicious for malignancy in needle biopsies histologic features and clinical significance in 33 cases . Am J Surg Pathol. 21:1997;1489-1495.
9. Sakr W.A., Tefilli M.V., Grignon D.J., et al. Gleason score 7 prostate cancer a heterogeneous entity? Correlation with pathologic parameters and disease-free survival . Urology. 56:2000;730-734.
10. Chan T.Y., Partin A.W., Walsh P.C., et al. Prognostic significance of Gleason score 3+4 versus Gleason score 4 + 3 tumor at radical prostatectomy. Urology. 56:2000;823-827.
11. Renshaw A.A., Richie J.P., Loughlin K.R., et al. Maximum diameter of prostatic carcinoma is a simple inexpensive, and independent predictor of prostate-specific antigen failure in radical prostatectomy specimens: validation in a cohort of 434 patients. Am J Clin Pathol. 111:1999;641-644.
12. Cheng L., Eichelberger L., Koch M., et al. Correlation of maximal tumor dimension with tumor volume in radical prostatectomy specimens. J Urol. 167:(suppl):2002;230-231.
13. Thorson P., Vollmer R.T., Arcangelli C., et al. Minimal carcinoma in prostate needle biopsy specimens diagnostic features and radical prostatectomy follow-up . Mod Pathol. 11:1998;543-551.
14. Iczkowski K.A., Bassler T.J., Schwob V.S., et al. Diagnosis of 'suspicious for malignancy' in prostate biopsies predictive value for cancer . Urology. 51:1998;749-758.
15. Epstein J.I. How should atypical needle biopsies be reported? Controversies regarding the term "ASAP." Hum Pathol. 30:1999;1401-1402.
16. Rabbani F., Stroumbakis N., Kava B.R., et al. Incidence and clinical significance of false-negative sextant prostate biopsies. J Urol. 159:1998;1247-1250.
17. DiGiuseppe J.A., Sauvageot J., Epstein J.I. Increasing incidence of minimal residual cancer in radical prostatectomy specimens. Am J Surg Pathol. 21:1997;174-178.